Introduction
The BCL‐2 family of proteins is responsible for regulating and executing the mitochondrial pathway of apoptosis. In addition, all three sub‐groups of the family—the pro‐survival members, the pro‐apoptotic effectors BAX and BAK, and the pro‐apoptotic BH3‐only activators/sensitizers—are also found in association with the endoplasmic reticulum (ER) in which they regulate and modulate both mitochondrial‐dependent and ‐independent apoptotic responses (
Heath‐Engel et al, 2008). More recently, several pro‐survival members and BH3‐only members have also been implicated in the regulation of macroautophagy (
Levine et al, 2008), a quality control and cellular‐survival mechanism that responds to conditions of nutrient and metabolic stress. In this pathway, pre‐autophagosomal vesicles mature by engulfing organelles and cytoplasmic complexes, encapsulating these contents within a double membrane vesicle, which subsequently fuses with lysosomes. The resulting degradation of autophagosomal contents regenerates macromolecule precursors that otherwise could not be generated if their metabolic biosynthesis was repressed (
Yorimitsu and Klionsky, 2005).
Recent studies suggest that pre‐autophagosomal vesicles are generated at an ER‐associated location, the omegasome, which represents a specialized, phosphatidylinositol 3‐phosphate (PI(3)P)‐enriched ER membrane platform for assembly of a phagosomal initiation complex (
Axe et al, 2008). This platform seems to be created through recruitment to the ER of vesicles‐containing Vps34, a class III phosphatidylinositol 3‐kinase (PI3K) that associates with Beclin 1 and other accessory proteins to generate a functional PI3K complex (
Kihara et al, 2001), thus resulting in enrichment of PI(3)P at this ER‐associated site (
Axe et al, 2008). The exact topography of the assembly of the PI3K complex at this site, however, remains to be determined. Beclin 1 is a haploinsufficient tumour suppressor and an important effector of autophagy, whose antagonism can be achieved by BCL‐2 that is located at the ER (
Liang et al, 1999;
Pattingre et al, 2005). Beclin 1 contains a BH3 domain that contributes to its interaction with BCL‐2, but the avidity of this interaction is quite weak compared with BH3 domains present in the BH3‐only proteins typically associated with apoptosis regulation (
Feng et al, 2007;
Oberstein et al, 2007). Moreover, BH3‐containing Beclin 1 does not seem to antagonize the anti‐apoptotic function of BCL‐2 at either the ER or mitochondria (
Ciechomska et al, 2009). Thus, canonical BH3‐only proteins such as BAD have been shown to displace Beclin 1 from BCL‐2 (
Maiuri et al, 2007), leading to the proposal that a signalling cascade analogous to the release of BCL‐2 antagonism by BH3‐only proteins in the apoptosis pathway also extends to autophagy (
Levine et al, 2008). In addition, phosphorylation of the Beclin 1 BH3 region by the death‐associated protein kinase (DAPk) pathway (
Zalckvar et al, 2009) or of BCL‐2 in the c‐Jun N‐terminal protein kinase (JNK) pathway (
Wei et al, 2008) has been linked to disruption of Beclin 1/BCL‐2 or BCL‐XL interactions. In addition to BCL‐2 interactions with Beclin 1 at the ER, BCL‐2 can also interact with BAX (
White et al, 2005), with the BAP31 complex (
Breckenridge et al, 2002), and with the calcium‐conducting inositol 1,4,5‐triphosphate (IP3) receptor (
Chen et al, 2004) at this location. In view of these multiple BCL‐2‐associated pathways at the ER and the relatively weak binding between BCL‐2 and Beclin 1, mechanisms presumably exist to ensure adequate partitioning of ER BCL‐2 to the autophagy pathway at this organelle. Emerging genetic (
Lam et al, 2008) and biochemical evidence (
Criollo et al, 2007;
Vicencio et al, 2009), for example, have identified the IP3 receptor complex as important in Beclin 1‐mediated autophagy, by providing a potential scaffold for regulating BCL‐2 and Beclin 1 interactions and/or for modulating autophagy in response to BCL‐2‐regulated stores of ER Ca
2+.
Here, we have identified a novel protein‐binding partner of BCL‐2 at the ER, nutrient‐deprivation autophagy factor‐1 (NAF‐1). The interaction between NAF‐1 and BCL‐2 is independent of a BH3 domain, but rather depends on the two iron–two sulphur (2Fe‐2S) coordinating CDGSH domain of NAF‐1. Whereas NAF‐1 is not required for BCL‐2 to interact with BH3‐only BIK, NAF‐1 contributes to the interaction of BCL‐2 with Beclin 1 and is required for BCL‐2 to functionally antagonize Beclin 1‐mediated cellular autophagy in response to nutrient deprivation of H1299 epithelial cells in culture. Of note, NAF‐1—similar to BCL‐2 and Beclin 1—is a component of the IP3 receptor complex and is required for BCL‐2 to depress ER Ca2+ stores. ER‐restricted NAF‐1, therefore, is a BCL‐2‐associated co‐factor that helps target BCL‐2 antagonism to the Beclin 1‐dependent autophagy pathway at the ER.
Discussion
This study reports the identity of NAF‐1, a small (15 kDa), earlier uncharacterized single‐spanning integral membrane protein located at the ER, and shows that NAF‐1 is a binding partner of BCL‐2 at this membrane. Using different methodologies, the results further indicate that NAF‐1 seems to be required for BCL‐2 at this site to inhibit Beclin 1‐mediated autophagy in response to nutrient deprivation in H1299 epithelial cells. Beclin 1 has been identified as a BH3‐only protein (
Oberstein et al, 2007), lending credence to the model that BCL‐2 antagonizes Beclin 1‐mediated autophagy through direct binding and inhibition of Beclin 1 (
Pattingre et al, 2005;
Maiuri et al, 2007). Given that Beclin 1 is a non‐membrane protein and has a weak BH3 domain (
Feng et al, 2007;
Oberstein et al, 2007), however, the fact that BCL‐2 located at the ER can inhibit Beclin 1 requires further elucidation. Recent work, for example, suggests that part of the class III PI3K population that is responsible for generating a PI(3)P‐enriched membrane compartment that can nucleate the formation of pre‐autophagosomal vesicles, may be assembled at a site associated with the ER (
Axe et al, 2008). Interestingly, a non‐membrane integrated constituent of this site that associates with PI(3)P (double FYVE domain‐containing protein 1) can also be delivered to this site when anchored to the ER membrane through a cytochrome b5 membrane anchor, suggesting that this site can be accessed by lateral diffusion within the ER bilayer. Assembly of the PI3K complex containing Vps34, Beclin 1, and accessory proteins that generates the PI(3)P‐enriched compartment at the ER likely involves delivery of Vps34‐containing vesicles to the vicinity of the ER, where Vps34 presumably interacts with Beclin 1 (
Axe et al, 2008). Interestingly, knockdown of NAF‐1 resulted in an unusual distribution of LC3 in starved cells, including at blebs or filopodia‐like structures at the cell periphery (
Figure 4B). As LC3 targets PI(3)P‐enriched membrane sites during autophagy, this may indicate that loss of NAF‐1 influences the normal biogenesis, distribution, or fate of PI(3)P in response to nutrient depletion.
One possibility is that the ER‐associated Beclin 1/Vps34 PI3K complex assembly site is also a site that can be accessed by the BCL‐2/NAF‐1 membrane‐integrated complex at the ER, targeting ER BCL‐2 to Beclin 1 for functional inhibition of the Beclin 1/Vps34 PI3K complex. In this context, in which BCL‐2 expression was targeted to the ER through BCL‐2b5, we showed a clear contribution of endogenous NAF‐1 to BCL‐2b5/Beclin 1 interactions using NAF‐1 siRNA (
Figure 5A). In contrast, NAF‐1 is not required for BCL‐2 interaction with BIK, and BIK is able to inhibit the interaction between BCL‐2 and NAF‐1 (
Figure 1E). The simplest explanation for why NAF‐1 targets BCL‐2 to the BIK autophagy pathway versus the apoptosis pathway, therefore, is that NAF‐1 is required for BCL‐2 to interact with and antagonize Beclin 1 interactions, but NAF‐1 is not required for BIK to interact with BCL‐2 and antagonize its anti‐apoptotic function.
A current model suggests that BCL‐2 constitutively interacts with Beclin 1 and prevents Beclin 1 from initiating autophagy. An autophagic stimulus such as nutrient deprivation, on the other hand, can result in changes to the phosphorylation status of BCL‐2 (
Wei et al, 2008) or Beclin 1 (
Zalckvar et al, 2009) to inhibit this interaction. Alternatively, Beclin 1/BCL‐2 interactions may be disrupted by a competing BH3‐only protein in response to the autophagic stimulus (
Maiuri et al, 2007). In the BCL‐2b5‐expressing cells used here, Beclin 1 was predominantly distributed throughout the cell as judged by immunofluorescence (data not shown), consistent with the idea that the BCL‐2/NAF‐1 complex at the ER is targeting a sub‐population of Beclin 1. NAF‐1 does not contain a BH3 domain, as expected if NAF‐1 promotes BCL‐2/Beclin 1 interactions (otherwise NAF‐1 would compete with Beclin 1 for interaction with BCL‐2). BH3‐independent interactions between BCL‐2 and certain binding partners have earlier been observed, notably the interaction between BCL‐2 and the IP3 receptor at the ER (
Rong et al, 2009). In the case of NAF‐1, we identified the CDGSH domain within the cytosolic region as being essential, but not sufficient for NAF‐1/BCL‐2 interactions. Despite the fact that NAF‐1 does not contain a canonical BH3 domain, we also found that the ER‐restricted BH3 protein, BIK, was able to displace NAF‐1 from BCL‐2. Emerging evidence, however, suggests that BCL‐2 undergoes significant conformational changes on binding of a potent BH3 ligand (
Dlugosz et al, 2006;
Shore and Nguyen, 2008). Although BIK is not a known physiological stimulus of autophagy and is not induced in response to nutrient deprivation, other more relevant BH3‐only proteins such as BAD (
Maiuri et al, 2007) might interfere with both the Beclin BH3‐ and the NAF‐1‐dependent (and potentially other) interactions with BCL‐2, disassembling the complex and freeing Beclin 1 from BCL‐2 inhibition.
As noted above, the displacement model for Beclin 1 activation assumes that Beclin 1 is constitutively constrained by BCL‐2 proteins and is activated on release from the BCL‐2 inhibitor. In this model, inhibition of autophagy by elevated BCL‐2 presumably arises because the autophagic stimulus cannot overcome the higher BCL‐2 sink for Beclin 1. Here, we show that NAF‐1 depletion interferes with the ability of BCL‐2 to interact with Beclin 1 and strongly overcomes the ability of BCL‐2 to inhibit Beclin 1‐mediated autophagy in response to nutrient deprivation. Of note, however, and in contrast to the model, depletion of NAF‐1 in the absence of a cell starvation stress (i.e. in control cells) does not result in a spontaneous induction of autophagy. This is analogous to the function of BCL‐2 in regulating BAX and BAK in response to an apoptotic stimulus (reviewed in
Shore and Nguyen, 2008). Knockdown or inhibition of pro‐survival BCL‐2 proteins leads to cell death only in ‘primed’ cells (i.e. cells in which sufficient levels of activator BH3‐only proteins or some other mechanism are present to activate BAX or BAK once the inhibition by the pro‐survival member is removed). In the absence of such a priming mechanism to activate BAX and BAK, then inhibition of pro‐survivals does not lead to cell death. Clearly, we show that knockdown of NAF‐1 on its own does not activate autophagy in cell lines maintained in 10% serum, but reduces the potential BCL‐2/Beclin 1 interaction. In contrast, NAF‐1 depletion coupled with nutrient deprivation resulted in enhanced autophagy compared with control cells. This could mean that additional Beclin 1 priming may be required for autophagy induction. It may be, for example, that activation of JNK, which leads to phosphorylation of BCL‐2 and disruption of BCL‐2/Beclin 1 interactions (
Wei et al, 2008), or of DAPk, which results in phosphorylation of the Beclin 1 BH3 domain (
Zalckvar et al, 2009) and disruption of BCL‐XL/Beclin 1 interactions, or a number of other stress pathways, results in both the inhibition of BCL‐2/Beclin 1 interactions and the activation of parallel ‘priming’ pathways that activate Beclin 1‐mediated autophagy, that is analogous to the regulation of BAX and BAK. Consistent with this model is the finding in mice that, in contrast to nutrient‐replete cell culture (this study), targeted deletion of the
wfs2 gene (
naf‐1/
cisd2/
eris) resulted in early onset ageing and mortality with evidence of autophagic cell death (
Chen et al, 2009). Of note, however, this study also reported that embryonic fibroblasts harbouring the
wfs2 gene deletion grew normally in complete medium. One explanation is that the accumulated stress in live animals coupled with loss of NAF‐1 expression ultimately leads to enhanced autophagy.
Genetic evidence in Dictyostelium has implicated the IP3 receptor in autophagy (
Lam et al, 2008) and a recent report has proposed that the receptor may constitute a platform to permit the inhibition of Beclin 1 by BCL‐2 (
Vicencio et al, 2009). In addition, BCL‐2‐mediated regulation of autophagy through ER Ca
2+ modulation has been reported (
Brady et al, 2007;
Hoyer‐Hansen et al, 2007; but see
Criollo et al, 2007). Given the direct involvement of BCL‐2 interaction with the IP3 receptor and regulation of ER Ca
2+ stores (
Heath‐Engel et al, 2008;
Pinton et al, 2008), we investigated the influence of NAF‐1. Similar to BCL‐2b5, endogenous NAF‐1 was found in physical association with IP3 receptor type 1. Moreover, elevated BCL‐2 at the ER can result in depressed levels of ER Ca
2+ stores in epithelial cells (
Distelhorst and Shore, 2004;
Pinton and Rizzuto, 2006), but this property of BCL‐2b5 was lost after knockdown of NAF‐1 by shRNA. Although further studies are required to determine whether and how the association of the NAF‐1/BCL‐2 complex with the IP3 receptor regulates autophagy, these findings serve to tie NAF‐1 to a major site of BCL‐2 regulation at the ER. Furthermore, mitochondrial damage was reported in aged mice harbouring the
wfs2 gene deletion (
Chen et al, 2009), a fact that can be explained by potential dysregulated Ca
2+ transmission from the ER to mitochondria through the IP3 receptor.
Finally, the point mutation in the
wfs2 gene results in the theoretical production of a severely truncated version of NAF‐1 (
Figure 1B), and it is this truncated gene product that represents the underlying aetiology of WFS2, a neurodegenerative condition (
Amr et al, 2007). As the WFS2 mutation removes a critical BCL‐2‐binding site within the cytosolic domain of NAF‐1, a key question for future studies is the consequences of defective regulation of NAF‐1 and presumably autophagy on this and perhaps other degenerative syndromes. Moreover, it will be important to determine whether gene deletion in mice recapitulates the
wfs2 mutation. At least provisionally, ectopic expression of the WFS2 mutant of NAF‐1 tagged with HA in H1299 cells, whose endogenous NAF‐1 was strongly knocked down by NAF‐1 shRNA (which does not target the WFS2 mutant), had no effect on starvation‐induced conversion of LC3 (
Supplementary Figure 6). Of interest, however, will be the fate of the WFS2 protein and phenotype of transgenic
wfs2‐null mice expressing the WFS2 protein.